Envoy Medical
COCH

Envoy Medical (COCH) analyst forecast and price target

Analyst forecast

Buy

Consensus of 2 analyst ratings

Buy
2
Hold
0
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
HC Wainwright & Co.MaintainedBuy$2.00 from $2.50Aug 21, 2026
LUCID CAPITAL MARKETSInitiated CoverageBuy$2.00Jul 27, 2026
HC Wainwright & Co.MaintainedBuy$2.50Jul 15, 2026
HC Wainwright & Co.Initiated CoverageBuy$2.50Mar 31, 2026
Ascendiant CapitalMaintainedBuy$9.50 from $9.25May 27, 2025
Ascendiant CapitalMaintainedBuy$9.25 from $9.00Apr 21, 2025
Ascendiant CapitalMaintainedBuy$9.00 from $8.75Dec 6, 2024
Brookline CapitalInitiated CoverageBuy$9.00Oct 14, 2024
Ascendiant CapitalMaintainedBuy$8.75 from $8.50Sep 3, 2024
Ascendiant CapitalInitiated CoverageBuy$8.50Jun 24, 2024
Lake StreetMaintainedBuy$6.00 from $3.00Apr 3, 2024
Northland Capital MarketsInitiated CoverageOutperformDec 21, 2023
Lake StreetInitiated CoverageBuy$3.00Nov 28, 2023

Frequently asked questions

  • Is COCH a buy, sell, or hold?

    Analysts covering Envoy Medical currently average a Buy rating: 2 buy, 0 hold and 0 sell, from 2 analysts. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on COCH?

    On Aug 21, 2026, HC Wainwright & Co. maintained Envoy Medical at Buy with a price target of $2.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.